Fused pyrazole derivatives as novel ERK inhibitors
US9242981B2 · kind B2 · utility
8Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2011 |
| Grant date | Jan 26, 2016 |
| Priority date | — |
| Expiry date | Sep 12, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are the ERK inhibitors of Formula (I): (Formula (I)) and the pharmaceutically acceptable salts thereof. All substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.